BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

11596

531633

LINCOLN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

LINCOLN PHARMA LTD performance

Today’s low

Today’s high

₹ 565.00 ₹ 589.40
₹ 567.50

52 week low

52 week high

₹ 499.00 ₹ 979.50
₹ 567.50

Open Price

₹ 585.00

Prev. Close

₹ 582.65

Volume (Shares)

26279.00

Total traded value

₹ 149.13

Upper Circuit

₹ 699.15

Lower Circuit

₹ 466.15

info

LINCOLN PHARMA LTD Share Price Update

As of the latest trading session, LINCOLN PHARMA LTD share price is currently at ₹ 565, which is down by ₹ -17.65 from its previous closing. Today, the stock has fluctuated between ₹ 565.00 and ₹ 589.40. Over the past year, LINCOLN PHARMA LTD has achieved a return of -1.91 %. In the last month alone, the return has been 5.51 %. Read More...

LINCOLN PHARMA LTD fundamentals


  • Market cap (Cr)

    1,131.68

  • P/E Ratio (TTM)

    12.72

  • Beta

    1.11

  • Book Value / share

    319.15

  • Return on equity

    17.04%

  • EPS (TTM)

    44.62

  • Dividend yield

    0.32%

  • Net profit/quarter (Cr)

    20.77

info icon alternate text
  • Market cap (Cr)

    1,131.68

  • P/E Ratio (TTM)

    12.72

  • Beta

    1.10

  • Book Value / share

    319.15

  • Return on equity

    17.04%

  • EPS (TTM)

    44.62

  • Dividend yield

    0.32%

  • Net profit/quarter (Cr)

    20.77

info icon alternate text

LINCOLN PHARMA LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 146.55
Operating Expense 126.84
Net Profit 20.77
Net Profit Margin (%) 14.17
Earnings Per Share (EPS) 10.37
EBITDA 32.63
Effective Tax Rate (%) 27.58
Particulars SEP 2024 (Values in Cr)
Revenue 161.21
Operating Expense 136.41
Net Profit 26.33
Net Profit Margin (%) 16.33
Earnings Per Share (EPS) 13.15
EBITDA 38.35
Effective Tax Rate (%) 24.29
Particulars JUN 2024 (Values in Cr)
Revenue 147.28
Operating Expense 128.21
Net Profit 23.67
Net Profit Margin (%) 16.07
Earnings Per Share (EPS) 11.82
EBITDA 33.14
Effective Tax Rate (%) 19.70
Particulars MAR 2024 (Values in Cr)
Revenue 142.49
Operating Expense 127.30
Net Profit 18.60
Net Profit Margin (%) 13.05
Earnings Per Share (EPS) 9.28
EBITDA 25.41
Effective Tax Rate (%) 16.29
Particulars DEC 2023 (Values in Cr)
Revenue 146.45
Operating Expense 119.75
Net Profit 28.04
Net Profit Margin (%) 19.14
Earnings Per Share (EPS) 14.00
EBITDA 40.67
Effective Tax Rate (%) 25.64
Particulars MAR 2024 (Values in Cr)
Revenue 580.55
Operating Expense 492.72
Net Profit 93.30
Net Profit Margin (%) 16.07
Earnings Per Share (EPS) 46.58
EBITDA 134.32
Effective Tax Rate (%) 23.67
Particulars MAR 2023 (Values in Cr)
Revenue 510.31
Operating Expense 432.34
Net Profit 72.90
Net Profit Margin (%) 14.28
Earnings Per Share (EPS) 36.40
EBITDA 111.66
Effective Tax Rate (%) 27.43
Particulars MAR 2022 (Values in Cr)
Revenue 472.08
Operating Expense 386.15
Net Profit 69.36
Net Profit Margin (%) 14.69
Earnings Per Share (EPS) 34.63
EBITDA 105.47
Effective Tax Rate (%) 27.69
Particulars MAR 2021 (Values in Cr)
Revenue 422.91
Operating Expense 344.98
Net Profit 62.25
Net Profit Margin (%) 14.71
Earnings Per Share (EPS) 31.08
EBITDA 92.78
Effective Tax Rate (%) 25.60
Particulars MAR 2020 (Values in Cr)
Revenue 376.09
Operating Expense 324.17
Net Profit 49.56
Net Profit Margin (%) 13.17
Earnings Per Share (EPS) 24.78
EBITDA 71.50
Effective Tax Rate (%) 22.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 295.98
ROE % 17.04
ROCE % 22.35
Total Debt to Total Equity 0.00
EBITDA Margin 23.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 250.86
ROE % 15.59
ROCE % 21.61
Total Debt to Total Equity 0.00
EBITDA Margin 21.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 216.12
ROE % 17.36
ROCE % 24.03
Total Debt to Total Equity 0.00
EBITDA Margin 22.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 182.92
ROE % 18.32
ROCE % 24.60
Total Debt to Total Equity 0.01
EBITDA Margin 21.89
Particulars MAR 2020 (Values in Cr)
Book Value / Share 156.54
ROE % 17.67
ROCE % 22.03
Total Debt to Total Equity 0.07
EBITDA Margin 19.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 295.98
ROE % 17.04
ROCE % 22.35
Total Debt to Total Equity 0.00
EBITDA Margin 23.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 250.86
ROE % 15.59
ROCE % 21.60
Total Debt to Total Equity 0.00
EBITDA Margin 21.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 216.12
ROE % 17.35
ROCE % 24.02
Total Debt to Total Equity 0.00
EBITDA Margin 22.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 182.92
ROE % 18.56
ROCE % 24.90
Total Debt to Total Equity 0.01
EBITDA Margin 21.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 152.25
ROE % 17.48
ROCE % 21.54
Total Debt to Total Equity 0.07
EBITDA Margin 19.01
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.83
Total Assets 700.29
Total Liabilities 700.29
Total Equity 592.83
Share Outstanding 20029728
Price to Book Ratio 1.98
Return on Assets (%) 13.32
Return on Capital (%) 15.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 34.31
Total Assets 587.42
Total Liabilities 587.42
Total Equity 502.47
Share Outstanding 20029728
Price to Book Ratio 1.35
Return on Assets (%) 12.41
Return on Capital (%) 14.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 18.79
Total Assets 534.35
Total Liabilities 534.35
Total Equity 432.87
Share Outstanding 20029728
Price to Book Ratio 1.44
Return on Assets (%) 12.97
Return on Capital (%) 15.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.84
Total Assets 452.35
Total Liabilities 452.35
Total Equity 366.39
Share Outstanding 20029728
Price to Book Ratio 1.23
Return on Assets (%) 13.76
Return on Capital (%) 16.97
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 14.58
Total Assets 389.38
Total Liabilities 389.38
Total Equity 313.47
Share Outstanding 20000000
Price to Book Ratio 0.88
Return on Assets (%) 13.21
Return on Capital (%) 16.17
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.38
Total Assets 700.14
Total Liabilities 700.14
Total Equity 592.83
Share Outstanding 20029728
Price to Book Ratio 1.98
Return on Assets (%) 13.32
Return on Capital (%) 15.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 33.84
Total Assets 587.25
Total Liabilities 587.25
Total Equity 502.47
Share Outstanding 20029728
Price to Book Ratio 1.35
Return on Assets (%) 12.41
Return on Capital (%) 14.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 18.43
Total Assets 534.11
Total Liabilities 534.11
Total Equity 432.87
Share Outstanding 20029728
Price to Book Ratio 1.44
Return on Assets (%) 12.98
Return on Capital (%) 15.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.43
Total Assets 451.80
Total Liabilities 451.80
Total Equity 366.39
Share Outstanding 20029728
Price to Book Ratio 1.23
Return on Assets (%) 13.77
Return on Capital (%) 16.97
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 11.21
Total Assets 367.20
Total Liabilities 367.20
Total Equity 304.49
Share Outstanding 20000000
Price to Book Ratio 0.88
Return on Assets (%) 13.49
Return on Capital (%) 16.05
Particulars MAR 2024 (Values in Cr)
Net Income 122.24
Cash from Operations 89.36
Cash from Investing -57.34
Cash from Financing -5.18
Net change in Cash 0.69
Free Cash Flow 128.84
Particulars MAR 2023 (Values in Cr)
Net Income 100.47
Cash from Operations 68.87
Cash from Investing -36.64
Cash from Financing -4.50
Net change in Cash -1.88
Free Cash Flow 83.13
Particulars MAR 2022 (Values in Cr)
Net Income 95.93
Cash from Operations 99.82
Cash from Investing -78.08
Cash from Financing -2.55
Net change in Cash -4.50
Free Cash Flow 145.35
Particulars MAR 2021 (Values in Cr)
Net Income 83.72
Cash from Operations 88.76
Cash from Investing -64.22
Cash from Financing -5.74
Net change in Cash -0.70
Free Cash Flow 97.51
Particulars MAR 2020 (Values in Cr)
Net Income 67.23
Cash from Operations 90.22
Cash from Investing -30.88
Cash from Financing -37.75
Net change in Cash 6.77
Free Cash Flow 97.91
Particulars MAR 2024 (Values in Cr)
Net Income 122.24
Cash from Operations 89.37
Cash from Investing -57.34
Cash from Financing -5.17
Net change in Cash 0.72
Free Cash Flow 128.84
Particulars MAR 2023 (Values in Cr)
Net Income 100.45
Cash from Operations 68.76
Cash from Investing -36.64
Cash from Financing -4.50
Net change in Cash -1.98
Free Cash Flow 83.02
Particulars MAR 2022 (Values in Cr)
Net Income 95.92
Cash from Operations 99.82
Cash from Investing -78.08
Cash from Financing -2.56
Net change in Cash -4.46
Free Cash Flow 145.34
Particulars MAR 2021 (Values in Cr)
Net Income 83.67
Cash from Operations 88.84
Cash from Investing -64.39
Cash from Financing -5.73
Net change in Cash -0.74
Free Cash Flow 97.59
Particulars MAR 2020 (Values in Cr)
Net Income 64.04
Cash from Operations 84.69
Cash from Investing -28.99
Cash from Financing -38.10
Net change in Cash 3.61
Free Cash Flow 91.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

LINCOLN PHARMA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
567.50 -2.60 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 579.50
  • 26 Days 571.90
  • 10 Days 577.40
  • 50 Days 589.10
  • 12 Days 575.90
  • 100 Days 626.90
  • 20 Days 571.70
  • 200 Days 644.50
588.25 PIVOT

First Support

571.30

First Resistance

599.60

Second Support

559.95

Second Resistance

616.55

Third Support

543.00

Third Resistance

627.90

RSI

48.21

ADX

21.07

MACD

3.98

Williams % R

-51.15

Commodity Channel Index (CCI)

32.20

Date

2025-04-30

Week

29852.00

Same Day

11113.00

Month

26608.00

1 Year

1.11

3 Year

0.86

Over 1 Month

5.51%

down

Over 1 Year

-1.91%

down

Over 3 Months

-17.06%

down

Over 3 Years

20.93%

down

Over 6 Months

-13.48%

down

Over 5 Years

29.42%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

LINCOLN PHARMA LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
45.22%
Promoter Holdings
49.77%
FII
4.99%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Munjal Mahendrabhai Patel 2678800.0 (13.37%) Shareholding of Promoter and Promoter Group
Aashish Rajanibhai Patel 2122902.0 (10.6%) Shareholding of Promoter and Promoter Group
Rajanikant Gulabdas Patel 756801.0 (3.78%) Shareholding of Promoter and Promoter Group
Mahendrabhai Gulabdas Patel 675000.0 (3.37%) Shareholding of Promoter and Promoter Group
Sunmed Corporation Llp 500000.0 (2.5%) Shareholding of Promoter and Promoter Group
Kailashben Mahendrabhai Patel 480000.0 (2.4%) Shareholding of Promoter and Promoter Group
Kishor M. Shah 478400.0 (2.39%) Public Shareholding
Downtown Travels Llp 475000.0 (2.37%) Shareholding of Promoter and Promoter Group
Hashmukhbhai Ishwarlal Patel 373600.0 (1.87%) Shareholding of Promoter and Promoter Group
Anand Arvinbhai Patel 332000.0 (1.66%) Shareholding of Promoter and Promoter Group
Rimo Capital Fund Lp 266450.0 (1.33%) Public Shareholding
Dheeraj Kumar Lohia 260816.0 (1.3%) Public Shareholding
Shivani Ashish Patel 206475.0 (1.03%) Shareholding of Promoter and Promoter Group
Mansi Munjal Patel 200000.0 (1.0%) Shareholding of Promoter and Promoter Group
Hansaben Arvindbhai Patel 177200.0 (0.88%) Shareholding of Promoter and Promoter Group
Patel Nishitkumar Maheshbhai 153400.0 (0.77%) Shareholding of Promoter and Promoter Group
Dharmisthaben Bhagirath Patel 124459.0 (0.62%) Shareholding of Promoter and Promoter Group
Arvindbhai Gulabdas Patel 111000.0 (0.55%) Shareholding of Promoter and Promoter Group
Downtown Finance Pvt. Ltd. 106000.0 (0.53%) Shareholding of Promoter and Promoter Group
Renukaben Maheshbhai Patel 98047.0 (0.49%) Shareholding of Promoter and Promoter Group
Patel Aniruddh H 86200.0 (0.43%) Shareholding of Promoter and Promoter Group
Jigar Hasmukhbhai Patel 86200.0 (0.43%) Shareholding of Promoter and Promoter Group
Mihir Viththalbhai Patel 82669.0 (0.41%) Shareholding of Promoter and Promoter Group
Dharmistaben Hasmukhbhai Patel 65003.0 (0.32%) Shareholding of Promoter and Promoter Group
Nidhi Mahendrabhai Patel 54000.0 (0.27%) Shareholding of Promoter and Promoter Group
Bhagirathbhai Tribhovandas Patel 24500.0 (0.12%) Shareholding of Promoter and Promoter Group
Amar Arvindbhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kalpanaben Rajnibhai Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shardaben Gulabdas Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Patel Siddharth Rajanikant 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Yogeshkumar Ishwerlal Patel 309.0 (0.0%) Shareholding of Promoter and Promoter Group
Minaben Yogeshkumar Patel 365.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

LINCOLN PHARMA LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
15 Sep 2023 1.5 Final 16 Sep 2023 Equity shares
15 Sep 2022 1.5 Final 17 Sep 2022 Equity shares
16 Sep 2021 1.5 Final 18 Sep 2021 Equity shares
05 Mar 2020 1.5 Interim 06 Mar 2020 Equity shares
19 Sep 2019 1.5 Final 21 Sep 2019 Equity shares
19 Sep 2018 1.5 Final 22 Sep 2018 Equity shares
21 Sep 2017 1.2 Final 23 Sep 2017 Equity shares
23 Sep 2016 1.0 Final 27 Sep 2016 Equity shares
23 Sep 2015 1.0 Final 26 Sep 2015 Equity shares
25 Sep 2014 0.6 Final 27 Sep 2014 Equity shares
19 Sep 2013 0.6 Final 21 Sep 2013 Equity shares
20 Sep 2012 0.6 Final 22 Sep 2012 Equity shares
22 Sep 2011 0.6 Final 24 Sep 2011 Equity shares
23 Sep 2010 1.2 Final 25 Sep 2010 Equity shares
17 Sep 2009 1.2 Final 19 Sep 2009 Equity shares
18 Sep 2008 0.24 Final 20 Sep 2008 Equity shares
20 Sep 2007 0.24 Final 22 Sep 2007 Equity shares
14 Sep 2006 0.0 Final 16 Sep 2006 Equity shares
25 Aug 2005 0.0 Final 29 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
19 Mar 2009 2.0 10.0 26 Mar 2009
08 Feb 2006 10.0 2.0 16 Feb 2006
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
15 Sep 2023 1.5 Final 16 Sep 2023 Equity shares
15 Sep 2022 1.5 Final 17 Sep 2022 Equity shares
16 Sep 2021 1.5 Final 18 Sep 2021 Equity shares
05 Mar 2020 1.5 Interim 06 Mar 2020 Equity shares
19 Sep 2019 1.5 Final 21 Sep 2019 Equity shares
19 Sep 2018 1.5 Final 22 Sep 2018 Equity shares
21 Sep 2017 1.2 Final 23 Sep 2017 Equity shares
23 Sep 2016 1.0 Final 27 Sep 2016 Equity shares
23 Sep 2015 1.0 Final 26 Sep 2015 Equity shares
25 Sep 2014 0.6 Final 27 Sep 2014 Equity shares
19 Sep 2013 0.6 Final 21 Sep 2013 Equity shares
20 Sep 2012 0.6 Final 22 Sep 2012 Equity shares
22 Sep 2011 0.6 Final 24 Sep 2011 Equity shares
23 Sep 2010 1.2 Final 25 Sep 2010 Equity shares
17 Sep 2009 1.2 Final 19 Sep 2009 Equity shares
18 Sep 2008 0.24 Final 20 Sep 2008 Equity shares
20 Sep 2007 0.24 Final 22 Sep 2007 Equity shares
14 Sep 2006 0.0 Final 16 Sep 2006 Equity shares
25 Aug 2005 0.0 Final 29 Aug 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
19 Mar 2009 2.0 10.0 26 Mar 2009
08 Feb 2006 10.0 2.0 16 Feb 2006

LINCOLN PHARMA LTD Share Price

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others.

The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.

The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project.

The Company launched Next Generation Progesterone Therapy 'ProlinSpray' during the year 2018.

During the year 2021-22, Lincoln Parenteral Limited, an erstwhile subsidiary, merged with the Company through Scheme of Amalgamation and Lincoln Parenteral Limited ceased to be a subsidiary of the Company.

The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.

Parent organization Indian Private
NSE symbol LINCOLN
Founded 1995
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Lincoln Pharmaceuticals Ltd?

Answer Field

The share price of Lincoln Pharmaceuticals Ltd for NSE is ₹ 565 and for BSE is ₹ 565.

What is the Market Cap of Lincoln Pharmaceuticals Ltd?

Answer Field

The market cap of Lincoln Pharmaceuticals Ltd for NSE is ₹ 11,31.68 Cr. and for BSE is ₹ 11,31.68 Cr. as of now.

What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Lincoln Pharmaceuticals Ltd for NSE is ₹ 979.50 and ₹ 499.00 and for BSE is ₹ 975.00 and ₹ 498.00.

How to Buy Lincoln Pharmaceuticals Ltd share?

Answer Field

You can trade in Lincoln Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Lincoln Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -6.13%.

What is the Current Share Price of Lincoln Pharmaceuticals Ltd?

Answer Field

Lincoln Pharmaceuticals Ltd share price is for NSE ₹ 565 & for BSE ₹ 565 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Lincoln Pharmaceuticals Ltd Share?

Answer Field

The market cap of Lincoln Pharmaceuticals Ltd for NSE ₹ 11,31.68 & for BSE ₹ 11,31.68 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Lincoln Pharmaceuticals Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Lincoln Pharmaceuticals Ltd share is 12.72.

What is the PB ratio of Lincoln Pharmaceuticals Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Lincoln Pharmaceuticals Ltd share is 319.15.

How to Buy Lincoln Pharmaceuticals Ltd Share?

Answer Field

You can trade in Lincoln Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lincoln Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Lincoln Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lincoln Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|